Neurogene Inc. (NGNE) Net income 2016–2025
Neurogene Inc. (NGNE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$90.4MFY2025 · since FY2016: -$37.0M → -$90.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$90.4M | -20.2% |
| FY2024 | -$75.1M | -106.9% |
| FY2023 | -$36.3M | +34.2% |
| FY2022 | -$55.2M | +9.1% |
| FY2021 | -$60.7M | -82.4% |
| FY2020 | -$33.3M | +52.1% |
| FY2019 | -$69.4M | -119.9% |
| FY2018 | -$31.6M | +37.1% |
| FY2017 | -$50.2M | -35.6% |
| FY2016 | -$37.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NGNE financial trends
NGNE RevenueNGNE Net marginNGNE Gross profitNGNE Gross marginNGNE Operating incomeNGNE Operating marginNGNE Operating cash flowNGNE Free cash flowNGNE Capital expendituresNGNE Return on equityNGNE Stock buybacksNGNE Dividends paidNGNE Total assetsNGNE Total liabilitiesNGNE Shareholders’ equityNGNE overview →